A Single Dose of the Selective Serotonin Reuptake Inhibitor Citalopram Exacerbates Anxiety in Humans: A Fear-Potentiated Startle Study
The DOI matches its Crossref record; 35 of the 36 references it cites were found in a registry or an index.
Abstract
Serotonin reuptake inhibitors may increase symptoms of anxiety immediately following treatment initiation. The present study examined whether acute citalopram increased fear-potentiated startle to predictable and/or unpredictable shocks in healthy subjects. Eighteen healthy subjects each received two treatments, placebo and 20 mg citalopram in a crossover design. Participants were exposed to three conditions including one in which predictable aversive shocks were signaled by a cue, a second in which unpredictable shocks were anticipated, and a third in which no shocks were administered. Changes in aversive states were investigated using acoustic startle stimuli. Citalopram did not affect baseline startle. However, the phasic startle potentiation to the threat cue in the predictable condition was robustly increased by acute citalopram. The sustained startle potentiation in the unpredictable conditions was also increased by citalopram, but only when the drug was given during the first session. These results indicate that a single dose of citalopram is not anxiogenic in itself, but can exacerbate the expression of fear and anxiety.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“although acute citalopram increased both fear and anxiety to predictable and unpredictable shock, respectively (Grillon et al, 2007)”
From Phasic vs Sustained Fear in Rats and Humans: Role of the Extended Amygdala in Fear vs Anxiety (2010) · cites this paper as Grillon et al, 2007
In the citing paper
“Seven days' treatment with citalopram, but not reboxetine, reduced the emotion-potentiated startle,25 and in line with clinical experience and effects on fearful face recognition, a single dose of citalopram potentiates this startle response.59”
From The effects of drugs on human models of emotional processing: an account of antidepressant drug treatment (2015) · cites this paper as [59]
In the citing paper
“Following both single doses of citalopram (reflecting possible early anxiogenic responses)28,59 and acute tryptophan depletion75 negative changes in emotional processing can be measured in healthy volunteer models”
From The effects of drugs on human models of emotional processing: an account of antidepressant drug treatment (2015) · cites this paper as [59]
Citations
Cites
(1970) · Cited by 24,983
Conscious and unconscious emotional learning in the human amygdala
Morris, J. S., Öhman, A., & Dolan, R. J. (1998) · Nature · doi:10.1038/30976 · Cited by 1,665 · cited 1×
“This would be consistent with findings that the amygdala can be activated without alteration in conscious mood (Morris et al, 1998).”
ResultClassical fear-conditioning in the anxiety disorders: a meta-analysis
Lissek, S., Powers, A. S., McClure, E. B., Phelps, E. A., Woldehawariat, G., Grillon, C., & Pine, D. S. (2005) · Behaviour Research and Therapy · doi:10.1016/j.brat.2004.10.007 · Cited by 1,034 · cited 1×
“…Group All rights reserved 0893-133X/07 $30.00 www.neuropsychopharmacology.org dure was implemented instead of a conditioning procedure given that abnormal responses to verbal threat more consistently characterize clinical anxiety states, relative to conditioning procedure (Lissek et al, 2005a, b).”
MethodSelf-citationRole of the bed nucleus of the stria terminalis versus the amygdala in fear, stress, and anxiety
Walker, D. L., Toufexis, D. J., & Davis, M. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01282-2 · Cited by 838 · cited 8×
“The amygdala is also involved in the initiation of sustained aversive responses (Walker et al, 2003).”
BackgroundMethodInfluentialGrillon, C., & Baas, J. (2003) · Clinical Neurophysiology · doi:10.1016/s1388-2457(03)00202-5 · Cited by 563 · cited 1×
“Moreover, this design focuses on modulatory influences on expressions of aversive responses rather than learning and memory processes inherently associated with associative learning procedures (Grillon and Baas, 2003).”
BackgroundSelf-citationAutoregulation of Serotonin Neurons: Role in Antidepressant Drug Action
Piñeyro, G., & Blier, P. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01417-0 · Cited by 537 · cited 4×
“The initially anxiogenic-like effects may result from an acute increased availability of serotonin on inhibitory 5HT1A autoreceptors, leading to a reduced firing of ascending serotonin raphe neurons, until adaptive changes ensue following chronic treatment (Piñeyro and Blier, 1999).”
BackgroundInfluentialFear‐Potentiated Startle in Humans: Effects of Anticipatory Anxiety on the Acoustic Blink Reflex
Grillon, C., AMELI, R., Woods, S. W., Merikangas, K., & Davis, M. (1991) · Psychophysiology · doi:10.1111/j.1469-8986.1991.tb01999.x · Cited by 462 · cited 1×
“Prior studies with this paradigm show that threat cues are very easy to discriminate from safe cues (Grillon et al, 1991).”
BackgroundSelf-citationAcute SSRI Administration Affects the Processing of Social Cues in Healthy Volunteers
Harmer, C. J., Bhagwagar, Z., Perrett, D. I., Völlm, B. A., Cowen, P. J., & Goodwin, G. M. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300004 · Cited by 420 · cited 7×
“This effect is consistent with clinical reports of symptom exacerbation following treatment initiation (Gorman et al, 1987; Ramos et al, 1993) and with evidence of facilitation of processing threat cues in experimental models following acute SSRIs (Burghardt et al, 2004; Harmer et al, 2003b).”
BackgroundResultInfluentialAnxious Responses to Predictable and Unpredictable Aversive Events.
Grillon, C., Baas, J. P., Lissek, S., Smith, K., & Milstein, J. (2004) · Behavioral Neuroscience · doi:10.1037/0735-7044.118.5.916 · Cited by 349 · cited 2×
“…two threat responses: a phasic fear-potentiated startle response associated with a cue and a more sustained startle potentiation generated by less explicit threat (Grillon et al, 2005, 2004) by administering predictable (ie signaled by a cue) or unpredictable (ie unsignaled) shocks, respectively.”
BackgroundResultSelf-citationSánchez, C., & Meier, E. (1997) · Psychopharmacology · doi:10.1007/s002130050181 · Cited by 255 · cited 1×
“In animals, acute serotonin can increase (Bagdy et al, 2001; Griebel et al, 1994) or decrease (Inoue et al, 1996, 2004; Sanchez and Meier, 1997) anxiety-like responses, depending on the model used.”
Background
Research works printed but not linked: 3
- First MB, Spitzer RI, Williams JBW, Gibbon M (1995). Structured Clinical Interview for DSM-V (SCID). American Psychiatric Association: Washington, DC.
- Phelps EA, O'Connor KJ, Gatenby JC, Anderson AK, Grillon C, Davis M et al (1998). Activation of the human amygdala by a cognitive representation of fear: an FMRI study. Soc Neurosci Abstr 24: 1524.
- Vertes RP, Fortin WJ, Crane AM (1999). Projections of the median raphe nucleus in the rat. J Comp Neurol 407: 555–582. · DOI · Paper page
Cited by
Items 101–162 of 162
Jawad, M. Y., Fatima, M., Hassan, U., Zaheer, Z., Ayyan, M., Ehsan, M. T., Khan, M. H. A., Qadeer, A., Gull, A. R., Asif, M. T., et al. (2023) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2871 · Cited by 17
Affective startle modulation in young people with first-presentation borderline personality disorder
Thompson, K. N., Allen, N. B., Chong, S. W., & Chanen, A. M. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.02.049 · Cited by 16
Llach, C.-D., Badulescu, S., Tabassum, A., Shah, H., Gill, H., Le, G. H., Vieta, E., McIntyre, R. S., Rosenblat, J. D., & Mansur, R. B. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03261-0 · Cited by 21
“This biphasic pattern — initial anxiogenesis followed by longer-term anxiolysis — resembles early treatment responses seen with selective serotonin reuptake inhibitors [139].”
A single oral dose of citalopram increases interoceptive insight in healthy volunteers
Livermore, J. J. A., Holmes, C. L., Moga, G., Adamatzky, K., Critchley, H., Garfinkel, S. N., & Campbell-Meiklejohn, D. K. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06115-7 · Cited by 20
“2016), and threat perception (Harmer and Cowen 2013; Garfinkel and Critchley 2016).”
Näslund, J., Landin, J., Hieronymus, F., Banote, R. K., & Kettunen, P. (2024) · Acta Neuropsychiatrica · doi:10.1017/neu.2024.44 · Cited by 14
Cole, S., Richardson, R., & McNally, G. P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058701 · Cited by 13
“These combined anxiolytic and anti-depressant properties are of particular note given that some commonly used anti-depressants can increase anxiety [40].”
BackgroundBernabe, C., Caliman, I. F., Truitt, W. A., Molosh, A. I., Lowry, C. A., Hay‐Schmidt, A., Shekhar, A., & Johnson, P. L. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881119900981 · Cited by 16
“For instance, in humans, taking citalopram prior to fear acquisition increases fear-potentiated startle response (Browning et al., 2007; Grillon et al., 2007), but chronically reduces conditioned fear response (Bui et al.”
BackgroundBijlsma, E. Y., Hendriksen, H., Baas, J. M. P., Millan, M. J., & Groenink, L. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.07.004 · Cited by 13
“The serotonin system is involved in fear regulation (Burghardt et al., 2004; Grillon et al., 2007a).”
Mood and personality effects in healthy participants after chronic administration of sertraline
Simmons, J. G., & Allen, N. B. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.06.007 · Cited by 13
“…increased recognition of fearful faces (e.g., Bhagwagar et al., 2004; Browning et al., 2007; Harmer et al., 2003), alterations in amygdala responsivity (Anderson et al., 2007; Bigos et al., 2008), and fear potentiated startle reflex augmentation (Browning et al., 2007; Grillon et al., 2007).”
BackgroundResultEffects of chronic fluoxetine treatment on anxious behaviour of BALB/c mice in a 3-dimensional maze
Abuhamdah, R. M. A., Hussain, M. D., Chazot, P. L., & Ennaceur, A. (2015) · Stress · doi:10.3109/10253890.2015.1083550 · Cited by 13
“It has been reported that the onset of action of SSRIs can be as long as six weeks after starting treatment (Gelenberg & Chesen, 2000; Nierenberg, 2001), and that the initial effect of treatment exacerbates anxiety (Gorman et al., 1987; Grillon et al., 2007).”
BackgroundParoxetine reduces crying in young women watching emotional movies
van der Veen, F. M., Jorritsma, J., Krijger, C., & Vingerhoets, A. J. J. M. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2477-z · Cited by 15
“The effect of paroxetine on crying as an emotional expression seemed to contradict the results of other studies examining other emotional expressions in mice (Gomes et al. 2009) and humans (Grillon et al. 2007).”
ResultEarly‐Onset Alcohol Dependence Increases the Acoustic Startle Reflex
Schellekens, A., Mulders, P. C. R., Ellenbroek, B. A., de Jong, C. A. J., Buitelaar, J. K., Cools, A. R., & Verkes, R. (2012) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2011.01700.x · Cited by 12
Hoge, E. A., Armstrong, C. H., Mete, M., Oliva, I. A., Lazar, S. W., Lago, T. R., & Grillon, C. (2023) · Biological Psychiatry · doi:10.1016/j.biopsych.2023.06.003 · Cited by 11
Self-citationGroenink, L., Verdouw, P. M., Zhao, Y., ter Heegde, F., Wever, K. E., & Bijlsma, E. Y. (2023) · Psychopharmacology · doi:10.1007/s00213-022-06307-1 · Cited by 13
“…response to non-cued trials)/startle response to non-cued trials)) validity of the human fear-potentiated test is, however, not unequivocal since benzodiazepines do not consistently reduce fear potentiation in healthy human subjects (Baas et al. 2002; Grillon et al. 2006 but see Riba et al. 2001).”
BackgroundInfluentialPettersson, R., Näslund, J., Nilsson, S., Eriksson, E., & Hagsäter, S. M. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3783-z · Cited by 12
“2007); moreover, it is likely to have bearing on the clinical observation that SSRIs may exert a paradoxical increase in anxiety during the first days of treatment (Browning et al. 2007; Grillon et al. 2007; Hetem et al. 1996; Rammsayer and Netter 1990; Sinclair et al. 2009).”
BackgroundResultInfluentialAndrews, P. W., & Amsterdam, J. D. (2020) · Psychiatria Polska · doi:10.12740/pp/120084 · Cited by 11
“In both rodents and humans, a single dose of SSRIs increases the symptoms of anxiety [89, 90] and potentiates fear responses [91–93].”
BackgroundChapter 4.1 Peptide receptor ligands to treat anxiety disorders
Steckler, T. (2008) · Handbook of behavioral neuroscience · doi:10.1016/s1569-7339(07)00010-0 · Cited by 13
Manganiello-Terra, F. A., Correa-Netto, N. F., Masukawa, M. Y., Ruzzi, A., Linardi, A., & Santos-Junior, J. G. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.113048 · Cited by 9
Payet, J. M., Stevens, L., Russo, A. M., Jaehne, E. J., van den Buuse, M., Kent, S., Lowry, C. A., Baratta, M. V., & Hale, M. W. (2023) · Neuroscience · doi:10.1016/j.neuroscience.2023.10.003 · Cited by 9
“In clinical laboratory settings using classical fear conditioning paradigms, a single dose of the SSRI citalopram enhances fear-potentiated startle responses when taken immediately prior to fear acquisi-58 tion (Browning et al., 2007; Grillon et al., 2007).”
Lambert, R., Caan, W., & McVicar, A. J. (2008) · Journal of Public Mental Health · doi:10.1108/17465729200800011 · Cited by 10
Selective effects of serotonin on choices to gather more information
Livermore, J. J. A., Holmes, C. L., Cutler, J., Levstek, M., Moga, G., Brittain, J. R., & Campbell-Meiklejohn, D. K. (2021) · Journal of Psychopharmacology · doi:10.1177/0269881121991571 · Cited by 7
“These doses have been shown to elicit cognitive changes in previous studies (Browning et al., 2007; Chamberlain et al., 2009; Grillon et al., 2007; Warren et al., 2017), and were chosen to balance active drug effects of interest against the potential for undesirable side effects.”
BackgroundAcute prazosin administration does not reduce stressor reactivity in healthy adults
Kaye, J. T., Fronk, G. E., Zgierska, A. E., Cruz, M. R., Rabago, D., & Curtin, J. J. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05297-x · Cited by 7
Mohammadi-Mahdiabadi-Hasani, M.-H., Ebrahimi-Ghiri, M., Khakpai, F., & Zarrindast, M. (2022) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-022-02242-2 · Cited by 6
Livermore, J. J. A., Skora, L. I., Adamatzky, K., Garfinkel, S. N., Critchley, H., & Campbell-Meiklejohn, D. K. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-02971-3 · Cited by 13
“In the lab, many of the same anxiety-linked responses that SSRIs acutely in fl uence will vary with interoceptive sensation — including startle [30 – 33], fear [34, 35], and emotion recognition [36 – 39].”
BackgroundYang, A., Daya, T., Carlton, K., Yan, J., & Schmid, S. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.12.025 · Cited by 7
“Previous studies have seen either no change in baseline startle by serotonergic modulation in rats (Geyer and Tapson, 1988; Martinez and Geyer, 1997) or an increase of baseline startle in humans after acute modulations (Liechti et al., 2001; Browning et al., 2007; Grillon et al., 2007).”
The Role of Serotonin in Aversive Inhibition: Behavioural, Cognitive and Neural Perspectives
Robinson, O. J., & Roiser, J. P. (2015) · Psychopathology Review · doi:10.5127/pr.034013 · Cited by 6
“Finally, it should also be noted that our model does not fully capture the nature of acute SSRI administration, which can have paradoxically anxiogenic effects (Di Simplicio et al., 2014; Grillon et al., 2006; Harmer, Bhagwagar et al., 2003; Harmer, Hill et al., 2003,).”
BackgroundThe role of serotonin in modulating common waxbill behaviour
Saldanha, B. C., Silva, P. A., Maximino, C., Cardoso, G. C., Trigo, S., & Soares, M. C. (2023) · Behavioral Ecology and Sociobiology · doi:10.1007/s00265-023-03316-8 · Cited by 7
“2012; Barry 2013), leading to a reduction of the firing rate of serotonergic neurons (Piñeyro and Blier 1999; Grillon et al. 2007; Homberg 2012), but also to its influence on the 5-HT2C pathway (de Moura et al.”
BackgroundInfluentialThe cognitive neuropsychological model of antidepressant response
Walsh, A. E. L., & Harmer, C. J. (2015) · Current Opinion in Psychology · doi:10.1016/j.copsyc.2014.12.022 · Cited by 6
Serotonergic Effects on InteroceptionPreprint
Livermore, J. J. A., Holmes, C. L., Moga, G., Adamatzky, K., Critchley, H., Garfinkel, S. N., & Campbell-Meiklejohn, D. K. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.08.28.262550 · Cited by 5
Ghimire, S., Kreilaus, F., Porto, R. R., Anderson, L. L., Yerbury, J. J., Arnold, J. C., & Karl, T. (2025) · Psychopharmacology · doi:10.1007/s00213-025-06785-z · Cited by 4
“However, the exact influence of serotonin signalling on fear is not completely clear as acute and chronic studies have discovered opposite effects when using selective serotonin reuptake inhibitor treatment (Burghardt et al. 2004; Grillon et al. 2007).”
Lukow, P. B., Lowther, M., Pike, A. C., Yamamori, Y., Chavanne, A. V., Gormley, S., Aylward, J., McCloud, T., Goble, T., Rodriguez-Sanchez, J., et al. (2024) · Journal of Psychopharmacology · doi:10.1177/02698811241286773 · Cited by 3
“…SSRI administration in rodents was found to increase anxiety-related behaviour, whereas chronic administration was reported to reduce it (Bocchio et al., 2016; Burghardt et al., 2004; Ravinder et al., 2013), mirroring findings in human psychophysiological research (Grillon et al., 2007, 2009).”
BackgroundResultLearned fear and innate anxiety in rodents and their relevance to human anxiety disorders
Gordon, J. A., & Adhikari, A. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511777578.018 · Cited by 2
Animal Models of Mood Disorders
Alcantara, L. F., Parise, E. M., & Bolaños‐Guzmán, C. A. (2017) · Oxford University Press eBooks · doi:10.1093/med/9780190681425.003.0026 · Cited by 4
Saadati, N., Bananej, M., Khakpai, F., Zarrindast, M., & Alibeik, H. (2022) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000703 · Cited by 2
Fear Not: Neurobiological Mechanisms of Fear and Anxiety
Klumpers, F. (2007) · Utrecht University Repository (Utrecht University) · Cited by 2
Livermore, J., Skora, L., Adamatzky, K., Garfinkel, S., Critchley, H., & Campbell-Meiklejohn, D. (2024) · medRxiv · doi:10.1101/2024.01.23.24301647
“33–36 ), fear (e.g. 17,37 ), and emotion recognition 38–41 .”
A systematic review of pharmacological effects on human aversive memory
Xia, Y., Quednow, B. B., & Bach, D. R. (2026) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2026.106548 · Cited by 1
Brunner, L.-M., Maurer, F., Weber, K., Weigl, J., Milenkovic, V. M., Rupprecht, R., Nothdurfter, C., & Mühlberger, A. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06111-x · Cited by 2
“The fact that self-reported anxiety related to U-threat and P-threat were not affected by any of the anxiolytic treatment is in line with previous studies that missed attenuating effects of anxiolytic or antidepressant compounds on respective self-reports (Grillon et al. 2006; Grillon et al. 2007).”
ResultFinn, J. L., & Nybell, L. M. (2001) · Cited by 1
Marković, V., Rizzo, G., Yavari, F., Vicario, C. M., & Nitsche, M. A. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.31.646182 · Cited by 1
Serotonin, cortisol, and stress-related psychopathology: from bench to bed
Tanke, M. A. C. (2009) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 1
SEROTONIN IN EMOTIONAL MEMORY PROCESSES: NEUROPHARMACOLOGICAL STUDIES WITH EMPHASIS ON DEPRESSION
Eriksson, T. (2012) · Figshare
Genetics in the Pathogenesis and Treatment of Panic and Anxiety
Wilson, J. (2014) · Otago University Research Archive (University of Otago)
Understanding the causes of anxiety
Simpson, H. B., Neria, Y., Lewis‐Fernández, R., & Schneier, F. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511777578.015
Rhodes, K. (2008) · ScholarWorks -A service of University of Vermont Libraries (University of Vermont)
Gao, Y. (2016) · doi:10.21007/etd.cghs.2016.0390
“promotes fear and anxiety-like behaviors both in rodents as well as in humans (Burghardt et al., 2004; Grillon et al., 2007), it is plausible that chronic enhancement of serotonergic transmission in the amygdala might allow anxiolytic-like effects to develop.”
BackgroundEarly effects of antidepressants on emotional processing
Komulainen, E. (2019) · Helda - University of Helsinki Institutional Repository
Morriss, J., Biagi, N., & Dodd, H. F. (2019) · PsyArXiv (OSF Preprints) · doi:10.31234/osf.io/ys4ju
Current awareness in human psychopharmacology
(2007) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.795
Neural and Behavioral Correlates of PTSD and Alcohol Use
Forster, G. L. (2014) · Defense Technical Information Center (DTIC) · doi:10.21236/ada610004
“In studies on healthy subjects, acute dosing of the SSRI citalopram can enhance recognition of fearful faces as well as increase emotion-potentiated startle response [204-206].”
BackgroundLewis, M. W., Bradford, D. E., Akman, E., Frederiks, K., Rauch, S. L., & Rosso, I. M. (2023) · Psychophysiology · doi:10.1111/psyp.14473 · Cited by 1
“For example, startle potentiation may be more sensitive to pharmacological (e.g., Selective Serotonin Reuptake Inhibitors, Prazosin, Benzodiazepines) interventions often used in conjunction with, or in place of behavioral therapy (Grillon et al., 2006; Grillon et al., 2007; Kaye et al., 2019).”
BackgroundJacobs, J. T., Maior, R. S., Waguespack, H. F., Campos-Rodríguez, C., Málková, L., & Forcelli, P. A. (2024) · Psychopharmacology · doi:10.1007/s00213-024-06651-4 · Cited by 1
“…- tration of SSRIs has been associated with increased anxiety both clinically, and in animal models (Burghardt and Bauer 2013; Gorman et al. 1987; Grillon et al. 2007; Mombereau et al. 2010; Ramos et al. 1993), whereas chronic use (presumably due to receptor desensitization) is associated with…”
Khakpai, F. (2024) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000794
“In contrast, some studies have reported that acute but not chronic treatment with SSRIs (such as citalopram) is capable of causing acute anxiogenic-like effects in rodents and humans (Matto and Allikmets, 1999; Grillon et al ., 2007, 2009; Mombereau et al ., 2010).”
Effects of SSRIs on the spatial transcriptome of dorsal raphe serotonin neurons
Henningson, C., Mlost, J., & Dorocic, I. P. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03644-x · Cited by 4
Influence of SSRI and SNRI co-prescription on benzodiazepine prescription trajectories
Kinney, K. L., Moreira-Junior, E. D. C., Berro, L. F., Morris, M. C., & Rowlett, J. K. (2025) · Drug and Alcohol Dependence Reports · doi:10.1016/j.dadr.2025.100325
“Pre-clinical (Bagdy et al., 2001; Griebel, 1995) and clinical (Gorman et al., 1987; Grillon et al., 2007) research indicates acute administration of SSRIs is associated with an anxiogenic effect.”
Neural Mechanisms in Primates Underlying Short- and Long-Term SSRI EffectsPreprint
Iskhakova, L., Perets, R., Yariv, S., & Paz, R. (2025) · Research Square · doi:10.21203/rs.3.rs-7223004/v1
Lukow, P. B., Lowther, M., Pike, A. C., Yamamori, Y., Chavanne, A. V., Gormley, S., Aylward, J., Vera, C. E., McCloud, T. L., Goble, T., et al. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.120682 · Cited by 2
On the anxiogenic influence of serotonin
Näslund, J. (2015) · Gothenburg University Publications Electronic Archive (Gothenburg University)
Beyond neurotransmission: the roles of serotonylation in physiological and pathological processes
Wang, J.-M., Zhang, F.-H., Chen, Y.-R., Chen, D.-N., Wang, X. L., Xie, H., Jiang-Feng, L. I., Luo, J.-D., & Xie, L.-P. (2026) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-026-00909-9 · Cited by 1
“This mechanism explained the initial anxiety exacerbation observed with selective serotonin reuptake inhibitors prior to therapeutic onset [63].”
Mu, X., Yan, J., Zheng, Y., Jiang, X., Weng, N., Lin, Y., Sha, W., & Chen, Y. (2026) · Behavioural Brain Research · doi:10.1016/j.bbr.2026.116415 · Cited by 1
Metadata
- Authors
- Grillon, C., Levenson, J., & Pine, D. S.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Grillon, Christian
- Venue
- Neuropsychopharmacology
- Published
- 2006-09-13
- Volume
- 32
- Issue
- 1
- Pages
- 225-231
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W2030071660
- Cited by
- 162
- References
- 36
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 6 · 2023: 10 · 2022: 4 · 2021: 5 · 2020: 8 · 2019: 4 · 2018: 5 · 2017: 5 · 2016: 6 · 2015: 15 · 2014: 10 · 2013: 11 · 2012: 11
- FWCI
- 3.90
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- citalopram, selective serotonin reuptake inhibitors, anxiogenic effects, fear potentiation, acoustic startle response, anxiety, acute drug effects
- MeSH terms
- Adolescent, Adult, Analysis of Variance, Anxiety, Double-Blind Method, Electroshock, Fear, Female, Humans, Male, Predictive Value of Tests, Reflex, Startle, Citalopram, Selective Serotonin Reuptake Inhibitors, Cross-Over Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.